TY - JOUR AU - Akateh, Clifford AU - Pawlik, Timothy M. AU - Cloyd, Jordan M. PY - 2018 TI - Adjuvant antiviral therapy for the prevention of hepatocellular carcinoma recurrence after liver resection: indicated for all patients with chronic hepatitis B? JF - Annals of Translational Medicine; Vol 6, No 20 (October 26, 2018): Annals of Translational Medicine Y2 - 2018 KW - N2 - Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide with an increasing incidence that affects all major demographic groups (1,2). Hepatitis B virus (HBV) infection is a major risk factor and leading cause of HCC development, accounting for approximately 33% of HCC cases worldwide (and up to 2/3 of cases in under-developed countries) (3,4). UR - https://atm.amegroups.org/article/view/20836